Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

News Conference News EuroPCR 2022

Better Durability With Self-Expanding TAVI? Clues From UK TAVI

May 18, 2022

April 2022 News Roundup

News Opinion CV Team Dispatch

April 2022 News Roundup

April 01, 2022

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

News Daily News

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Michael O'Riordan

March 21, 2022

Good Results For TAVI in Bicuspid Valves, But Questions Persist

News Daily News

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Michael O'Riordan

March 08, 2022

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan

News Daily News

‘Considerable’ Aortic Stenosis Burden in UK Begs Money and a Plan

Michael O'Riordan

January 28, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.